Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting
Clinical trial NCT03808688 · COMPLETED
Trial details
- NCT number
- NCT03808688
- Sponsor
- Aerie Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-27
- Primary completion
- 2019-07-26
- Enrollment
- 261
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.